Skip Navigation National Cancer Institute U.S. National Institutes of Health www.cancer.gov
 
OverviewFunding OpportunitiesResources

Research on Malignancies in the Context of HIV/AIDS

arrow icon NIH/PEPFAR Collaboration for Implementation Science (Admin Sup)
arrow icon U.S.-South Africa Program for Collaborative Biomedical Research (R01)
arrow icon U.S.-South Africa Program for Collaborative Biomedical Research (R21)
arrow icon Multidisciplinary Studies of HIV/AIDS and Aging (R01)
arrow icon Research on Malignancies in the Context of HIV/AIDS (R21)
arrow icon Multidisciplinary Studies of HIV/AIDS and Aging (R03)
arrow icon Sub-Saharan African Collaborative HIV and Cancer Consortia (U54)
arrow icon Biomarkers of Infection-Associated Cancers
arrow icon Centers for AIDS Research (CFARs)

NIH/PEPFAR Collaboration for Implementation Science (Admin Sup)

The intent of this funding opportunity announcement is to encourage scientific research of relevance to PEPFAR programs that will focus on the multiple challenges being encountered by many programs in resource-limited countries when they attempt to deploy effective prevention, treatment, and integrated interventions against HIV/AIDS. Studies should reflect the needs and priorities of the countries or regions in which they are to be conducted, but also produce results that are quantifiable and applicable to diverse circumstances and geographic areas. Another objective is to incorporate capacity building and/or local investigators in the proposed work.

Additional information:

U.S.-South Africa Program for Collaborative Biomedical Research (R01)

The intent of this funding opportunity announcement is to foster, stimulate, and/or expand basic, translational, behavioral and applied research that will advance scientific discovery and engage U.S. and South African researchers working collaboratively in the areas of TB, HIV/AIDS biomedical and behavioral science, and HIV-related co-morbidities, including malignancies. Clinical trials (any phase) are not supported under this FOA. Proposed research should reflect the highest possible scientific standards, as well as shared interests, international and local public health needs and priorities, and involve mutually advantageous collaborations among institutions, including participating communities and other partners.

Additional information:

U.S.-South Africa Program for Collaborative Biomedical Research (R21)

The intent of this funding opportunity announcement is to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development in the areas of basic, translational, behavioral and applied research that will advance scientific discovery and engage U.S. and South African researchers working collaboratively in the areas of TB, HIV/AIDS biomedical and behavioral science, and HIV-related co-morbidities, including malignancies. Clinical trials (any phase) are not supported under this FOA. Proposed research should reflect the highest possible scientific standards, as well as shared interests, international and local public health needs and priorities, and involve mutually advantageous collaborations among institutions, including participating communities and other partners.

Additional information:

Research on Malignancies in the Context of HIV/AIDS (R01)

The intent of this initiative is to solicit applications to advance our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying HIV infection or AIDS. This FOA encourages research efforts that will (i) provide information on the clinical outcomes of such cancers in the HIV-infected population and (ii) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers. Ultimately, such efforts could inform screening approaches and therapies targeted to the HIV-infected population.

Additional information:

Research on Malignancies in the Context of HIV/AIDS (R21)

The intent of this initiative is to solicit applications to advance our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying HIV infection or AIDS. This FOA encourages research efforts that will (i) provide information on the clinical outcomes of such cancers in the HIV-infected population and (ii) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers. Ultimately, such efforts could inform screening approaches and therapies targeted to the HIV-infected population.

Additional information:

Multidisciplinary Studies of HIV/AIDS and Aging (R03)

The intent of this initiative is to solicit applications to study HIV infection, HIV-associated conditions including cancer, HIV treatment, and/or biobehavioral or social factors associated with HIV/AIDS in the context of aging and/or in older adults. Research approaches of interest include clinical translational, observational, and intervention studies in domestic and international settings.

Additional information:

Sub-Saharan African Collaborative HIV and Cancer Consortia (U54)

The intent of this initiative is to promote and facilitate research on HIV and cancer in Africa through collaborative efforts between investigators in U.S. and investigators in sub-Saharan African countries. The FOA solicits applications for Specialized Center Cooperative Agreements (U54) for research on HIV-associated cancers. Each application must be based on collaborations between researchers in a U.S. institution and researchers in one sub-Saharan African country. Each applicant team is required to propose between two to four research projects that address high-priority questions relevant to the African country. The proposed projects may range, as appropriate, from basic research to translational efforts as well as population and implementation studies. Clinical trials, however, will not be supported.

Additional information:

Biomarkers of Infection-Associated Cancers

This initiative is designed to foster research to increase our knowledge of infectious agent-associated malignancies and identify those who are at increased risk of developing cancer among infected individuals and to detect early stage cancers in this population. Research projects proposed in the applications may involve a number of infectious agents showing associations with cancer. Noteworthy viral agents of interest to this program are human papillomavirus (HPV), Hepatitis B and C viruses, Epstein-Barr virus (EBV), and Simian Virus 40. Furthermore, an escalating prevalence of early cervical, lung, and colon cancers has emerged among HIV patients.

Additional information:

Centers for AIDS Research (CFARs)

The CFAR program provides administrative and shared research support to synergistically enhance and coordinate high quality AIDS research projects. CFARs accomplish this through core facilities that provide expertise, resources, and services not otherwise readily obtained through more traditional funding mechanisms. CFARs improve the institutions’ ability to carry multidisciplinary AIDS research and provide unique flexibility to respond to evolving scientific needs in AIDS research.

Additional information: